Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts (Q46604612)

23 December 2017

title

Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts (English)

1 reference

23 December 2017

author

Yingjie Chen

1

1 reference

23 December 2017

author name string

Yunfang Li

2

1 reference

23 December 2017

Ping Zhang

3

1 reference

23 December 2017

Jay H Traverse

4

1 reference

23 December 2017

Mingxiao Hou

5

1 reference

23 December 2017

Xin Xu

6

1 reference

23 December 2017

Masumi Kimoto

7

1 reference

23 December 2017

Robert J Bache

8

1 reference

23 December 2017

publication date

15 July 2005

1 reference

23 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

23 December 2017

volume

289

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

H2212-9

1 reference

23 December 2017

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Nitric oxide modulates myocardial oxygen consumption in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Alterations of gene expression in failing myocardium following left ventricular assist device support

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00224.2005

10.1152/AJPHEART.00224.2005

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017